Solstein Capital’s Pfizer PFE Stock Holding History

Solstein Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$69.9K	Hold	2,903	–	–	0.02%	207
2026 Q1	$81.5K	Hold	2,903	–	–	0.03%	192
2025 Q4	$72.3K	Sell	2,903 -450	-13%	-$11.3K	0.03%	186
2025 Q3	$85.4K	Sell	3,353 -1,720	-34%	-$42.5K	0.02%	165
2025 Q2	$123K	Buy	5,073 +1,270	+33%	+$29.6K	0.06%	139
2025 Q1	$96.4K	Hold	3,803	–	–	0.06%	132
2024 Q4	$101K	Hold	3,803	–	–	0.06%	129
2024 Q3	$110K	Hold	3,803	–	–	0.06%	127
2024 Q2	$106K	Hold	3,803	–	–	0.07%	125
2024 Q1	$106K	Sell	3,803 -452	-11%	-$12.5K	0.07%	118
2023 Q4	$123K	Hold	4,255	–	–	0.09%	112
2023 Q3	$141K	Hold	4,255	–	–	0.12%	100
2023 Q2	$156K	Hold	4,255	–	–	0.13%	93
2023 Q1	$174K	Hold	4,255	–	–	0.15%	89
2022 Q4	$218K	Hold	4,255	–	–	0.18%	86
2022 Q3	$186K	Hold	4,255	–	–	0.16%	84
2022 Q2	$223K	Hold	4,255	–	–	0.17%	92
2022 Q1	$220K	Hold	4,255	–	–	0.15%	107
2021 Q4	$251K	Hold	4,255	–	–	0.15%	117
2021 Q3	$183K	Buy	4,255 +450	+12%	+$19.9K	0.11%	137
2021 Q2	$149K	Buy	3,805 +1,921	+102%	+$74.7K	0.18%	126
2021 Q1	$68K	Buy	+1,884	New	+$66.9K	0.09%	187
2020 Q4	–	Sell	-2,228	Closed	-$78K	–	177
2020 Q3	$78K	Hold	2,228	–	–	0.17%	105
2020 Q2	$69K	Hold	2,228	–	–	0.16%	97
2020 Q1	$69K	Buy	2,228 +242	+12%	+$8.25K	0.27%	64
2019 Q4	$74K	Buy	+1,986	New	+$70.7K	0.15%	90

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Solstein Capital's PFE Position: Q2 2026 in Review

Solstein Capital held its Pfizer (PFE) position steady in Q2 2026 at 2,903 shares worth $69.9K. The position accounts for 0.02% of the portfolio, ranked #207.

Solstein Capital first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $251K in Q4 2021. 2,829 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Solstein Capital held 2,903 shares of Pfizer worth $69.9K as of Q2 2026.
Solstein Capital left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.02% of Solstein Capital's portfolio in Q2 2026, its #207 holding.
Solstein Capital first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
Solstein Capital's Pfizer position peaked at $251K in Q4 2021.
2,829 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.